UPEXI, INC.
For the period ended Jun 30, 2025. Filed Sep 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 24, 2025
UPXI$0.66+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| UPEXI, INC. | ||
|---|---|---|
| CONSOLIDATED BALANCE SHEETS | ||
| June 30, | June 30, | |
| 2025 | 2024 | |
| ASSETS | ||
| Current assets | ||
| Cash | $2,975,150 | $661,415 |
| Accounts receivable, net | 157,515 | 606,885 |
| Inventory, net | 1,152,870 | 1,431,556 |
| Due from VitaMedica transition | 228,017 | 212,358 |
| Prepaid expenses and other receivables | 350,836 | 502,188 |
| Current digital assets at fair value | 49,913,655 | - |
| Assets available for sale - Building | - | 4,005,516 |
| Purchase price receivable - VitaMedica | 2,000,000 | 2,000,000 |
| Purchase price receivable - E-core | - | 2,000,000 |
| Total current assets | 56,778,043 | 11,419,918 |
| Property and equipment, net | 2,052,573 | 2,356,556 |
| Intangible assets, net | 163,113 | 239,871 |
| Goodwill | 848,854 | 848,854 |
| Deferred tax asset | 5,948,858 | 5,948,858 |
| Digital assets at fair value, net of current | 56,083,525 | - |
| Other assets | 192,123 | 278,435 |
| Right-of-use asset, net | 1,739,755 | 2,418,596 |
| Total other assets | 67,028,801 | 12,091,170 |
| Total assets | $123,806,844 | $23,511,088 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $1,039,370 | $481,647 |
| Accrued compensation | 3,470,296 | 1,098,856 |
| Deferred revenue | 13,155 | 235,255 |
| Accrued liabilities | 356,064 | 736,407 |
| Accrued interest | 792,449 | 476,018 |
| Acquisition payable | 260,652 | 413,152 |
| Related party advances, net | - | 100,000 |
| Current portion of note payable | 560,000 | - |
| Short-term treasury debt | 20,000,000 | - |
| Current portion of Cygnet subsidiary notes payable | 5,380,910 | 5,447,565 |
| Note payable on building for sale | - | 2,634,538 |
| Current portion of operating lease payable | 691,010 | 1,031,714 |
| Total current liabilities | 32,563,906 | 12,655,152 |
| Operating lease payable, net of current portion | 1,145,440 | 1,732,606 |
| Related party note payable | - | 500,000 |
| Note payable | - | 557,429 |
| Convertible notes payable | - | 1,550,000 |
| Total long-term liabilities | 1,145,440 | 4,340,035 |
| Commitments and contingencies | ||
| Stockholders' equity | ||
| Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 and 25,000 shares issued and outstanding, respectively | 2 | 1 |
| Common stock, $0.00001 par value, 300,000,000 shares authorized, and 38,270,571 and 1,045,429 shares issued and outstanding, respectively | 383 | 11 |
| Additional paid in capital | 150,640,935 | 53,375,502 |
| Accumulated deficit | (60,543,822) | (46,859,613) |
| Total stockholders' equity attributable to Upexi, Inc. | 90,097,498 | 6,515,901 |
| Total stockholders' equity | 90,097,498 | 6,515,901 |
| Total liabilities and stockholders' equity | $123,806,844 | $23,511,088 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.